We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
OneMain Financial
OMF
$6.97B
| $227K | ﹤0.01% |
5,186
+391
| +8% | +$15.3K |
|
1527
TaskUs
TASK
$748M
| $226K | ﹤0.01% |
20,000
| – | – |
|
|
PDCO
1528
DELISTED
Patterson Companies, Inc.
PDCO
| $222K | ﹤0.01% |
6,670
-238
| -3% | -$6.56K |
|
1529
Greif
GEF
$4.71B
| $221K | ﹤0.01% |
3,215
-332
| -9% | -$21.3K |
|
|
PFC
1530
DELISTED
Premier Financial Corp. Common Stock
PFC
| $220K | ﹤0.01% |
13,763
-262
| -2% | -$4.31K |
|
1531
Sempra
SRE
$53.4B
| $218K | ﹤0.01% |
2,998
-554
| -16% | -$41.6K |
|
1532
Datadog
DDOG
$82.9B
| $217K | ﹤0.01% |
2,210
-1,287
| -37% | -$108K |
|
1533
PACCAR
PCAR
$62.2B
| $211K | ﹤0.01% |
2,528
-45
| -2% | -$3.33K |
|
1534
HP
HPQ
$29.5B
| $210K | ﹤0.01% |
6,847
+573
| +9% | +$17.2K |
|
|
ILPT
1535
Industrial Logistics Properties Trust
ILPT
$513M
| $209K | ﹤0.01% |
+63,451
| New | +$142K |
|
1536
Triumph Financial Inc
TFIN
$1.52B
| $209K | ﹤0.01% |
3,444
-78,921
| -96% | -$4.34M |
|
1537
Monster Beverage
MNST
$87.3B
| $208K | ﹤0.01% |
7,256
+2,596
| +56% | +$73.8K |
|
|
NPKI
1538
NPK International
NPKI
$1.1B
| $208K | ﹤0.01% |
39,749
-3,104
| -7% | -$12.9K |
|
|
TBHC
1539
DELISTED
The Brand House Collective
TBHC
| $206K | ﹤0.01% |
74,012
-102,320
| -58% | -$296K |
|
1540
Kohl's
KSS
$1.87B
| $205K | ﹤0.01% |
8,894
-642
| -7% | -$13.9K |
|
1541
Ameren
AEE
$28.5B
| $204K | ﹤0.01% |
2,497
+119
| +5% | +$10.2K |
|
1542
Teledyne Technologies
TDY
$27.9B
| $196K | ﹤0.01% |
477
+441
| +1,225% | +$182K |
|
1543
Helen of Troy
HELE
$634M
| $196K | ﹤0.01% |
1,814
-1,976
| -52% | -$189K |
|
1544
UDR
UDR
$11.1B
| $195K | ﹤0.01% |
4,545
-3,396
| -43% | -$140K |
|
1545
1-800-Flowers.com
FLWS
$174M
| $194K | ﹤0.01% |
24,847
-4,057
| -14% | -$37.2K |
|
1546
Old Dominion Freight Line
ODFL
$36.2B
| $193K | ﹤0.01% |
1,046
-422
| -29% | -$68.3K |
|
1547
Leidos
LDOS
$16.2B
| $191K | ﹤0.01% |
2,160
-731
| -25% | -$62.3K |
|
1548
Information Services Group
III
$255M
| $189K | ﹤0.01% |
35,196
-2,459
| -7% | -$12.7K |
|
1549
Rocket Pharmaceuticals
RCKT
$382M
| $188K | ﹤0.01% |
9,481
-1,701
| -15% | -$34.4K |
|
1550
iShares Russell 2000 ETF
IWM
$76.5B
| $182K | ﹤0.01% |
972
+490
| +102% | +$87.4K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.